logo

Artificial intelligence-enabled microfluidic analysis of ciliary beat defects for drug discovery, biomedicine, and disease screening

Location: Germany

Source: EU Funding & Tenders Portal

Project
Ongoing

In Ai4Cilia (“Artificial intelligence for Cilia”), we will develop an automated microfluidic AI-powered assay of ciliated cells to detect and classify ciliary beat abnormalities for drug discovery, biomedicine, and disease screening. Rhythmically beating ciliated cells perform important physiological functions in the airways and the reproductive system. Defects of ciliary beat contribute to debili

Project Information FAQ

Project Information

3 Q
The project “Artificial intelligence-enabled microfluidic analysis of ciliary beat defects for drug discovery, biomedicine, and disease screening” is an infrastructure initiative, located in Germany. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Want to explore the full details? View the full report

Participants

Sponsoring Agency

Obfuscated Data

Company

Obfuscated Data

Status

Original status

ongoing

Taiyo status

Obfuscated Data

Taiyo last update

00-00-0000

Available timestamps

00-00-0000

Available timestamp type

Obfuscated Data

Contact

Contact name

Obfuscated Data

Phone

0000000000

Email

ObfuscatedData@email.com

Address

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description

Description

In Ai4Cilia (“Artificial intelligence for Cilia”), we will develop an automated microfluidic AI-powered assay of ciliated cells to detect and classify ciliary beat abnormalities for drug discovery, biomedicine, and disease screening. Rhythmically beating ciliated cells perform important physiological functions in the airways and the reproductive system. Defects of ciliary beat contribute to debilitating diseases, such as to-date uncurable chronic obstructive pulmonary disease (COPD), and underdiagnosed causes of infertility. In the context of our ERC StG MecCOPD, we recently showed that standard video-microscopy recordings of ciliary beat can be used to extract quantitative metrics that clearly identify disease-specific ciliary dysfunction. Therefore, since ciliary beat can be observed in vitro and in minimally invasive biopsies, it could provide a much-needed readout for drug development and improved diagnosis. However, since ciliary beat patterns are highly complex, it takes specialists to analyze them and hence this information is rarely exploited in praxis. To establish ciliary beat as a common readout, we developed a microfluidic platform that standardizes data acquisition from ciliated cells and uses AI for detecting and classifying ciliary beat defects. To bring this approach to the next level and towards market entry, we will address three key objectives in Ai4Cilia to demonstrate (1) hardware feasibility by validating human ciliated cell capture and data acquisition in our microfluidic chip; (2) software feasibility by training our AI algorithm to detect disease-specific ciliary defects and validate sensitivity and specificity of our assay; and (3) business feasibility by assessing customer needs in biomedical and clinical research to define the most efficient go-to-market strategy. We believe this strategy will make ciliary beat a highly sensitive and robust readout for respiratory and reproductive (dys)function in biomedical and clinical research.

Original sub-sector

Obfuscated

Original Currency

USD

Original budget

000000000000000

Procurement method

Obfuscated Data

Budget

000000000000000

Location

Region

Obfuscated

Country

Obfuscated

State

Obfuscated Data

County

Obfuscated

Location

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source

Source reliability

High

Data quality score

100%

Source

Obfuscated Data

URL

obfuscated_data,obfuscateddata.com

More Details

Project Type

Obfuscated Data

Article Published Date

Obfuscated Data